Pacira | PCRX - Capitale Sociale E Riserve





Capitale Sociale E Riserve Cambiamento Data
Astellas Pharma JPY 1.83T 65.92B 2026-03
Bristol-Myers Squibb USD 20.07B 1.6B 2026-03
Cara Therapeutics USD 20.95M 6.92M 2025-12
Coherus Biosciences USD 61.01M 26.76M 2025-12
Heron Therapeutics USD 9.14M 4.15M 2026-03
Ironwood Pharmaceuticals USD -217.14M 44.69M 2026-03
J&J USD 81.19B 358M 2026-03
Ligand Pharmaceuticals USD 997.32M 19.89M 2026-03
Nektar Therapeutics USD 89.83M 4.75M 2025-12
Novo Nordisk DKK 203.07B 9.02B 2026-03
Omeros USD -228.68M 15.13M 2025-06
Pacira USD 653.89M 39.22M 2026-03
Perrigo USD 2.5B 436.7M 2026-03
Pfizer USD 90.1B 3.63B 2026-03
Supernus Pharmaceuticals USD 1.08B 15.09M 2026-03
Teva Pharmaceutical Industries USD 8.23B 314M 2026-03
Xeris Pharmaceuticals USD 13.01M 678K 2026-03
Xoma USD 87.94M 15.5M 2025-09
Zoetis USD 3.23B 98M 2026-03